Innovation is being used to improve quality metrics in oncology care at the patient forefront and in data, explained Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates.
Innovation is being used to improve quality metrics in oncology care when it comes to the patient and in data, explained Lani M. Alison, BSN, MS, HCQ, PCMH, CCE, vice president of Clinical Affairs, Regional Cancer Care Associates.
Transcript
How is innovation being used to improve quality metrics in oncology care?
Innovation is being used in many different ways. There’s innovation at the patient forefront, and then there’s also innovation in data. So, what I really deal with is pretty much data that is then translated into the practice, and we need to have evidence-based data in studies that is really written by innovation. When we have innovative patient assistance, for example, or innovative strategies to improve patient outcomes, this has really been very helpful. When we say, “so is this an innovation or is this what we have done before?” innovation can be a new way of doing things from already proven tactics.
For example, care management. Care management was an innovation a few years ago, maybe 10 years ago, so we then improved it to care coordination. When we care manage patients, it’s not only with a provider that has given the opportunity to care manage a patient, but also it goes beyond that to other providers that are also taking care of the patients. So, that is an innovation in the way we manage patients outside of the acute care facilities.
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Expanding Access to NSCLC Innovations: Challenges and Opportunities
October 18th 2024The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and improving treatment access, in particular for immunotherapy and targeted treatments.
Read More
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More